Leader in Biomedical Textiles Expands National Sales Capabilities, Hires Kyle Mullens and Tim McGinnis
Perkasie, Penna. – September 16, 2009 – Secant Medical™, the leader in the design, development, and custom manufacture of biomedical textile structures, announces it has expanded its national sales team by hiring two business development specialists with expertise in the medical device industry. The company has added Kyle Mullens as director of business development, Orthopedics and Tim McGinnis as director of business development, Cardiovascular as part of a recent initiative to bolster its marketing and sales efforts for its fiscal year 2010, which began September 1.
Mullens' experience includes sales and product management work for K2M Inc., a spinal device company specializing in surgical solutions for complex spinal pathologies, where he created product commercialization programs to help drive surgeon adoption and spur sales growth. Mullens, who holds a B.S. in Plastics Engineering from Ferris State University in Michigan, previously managed business development responsibilities for A. Schulman Inc., a key supplier of polymer resin to the medical, packaging and automotive industries. At Secant Medical, he will be responsible for expanding sales growth in the orthopedics market segment.
Before joining Secant Medical, McGinnis served as global sales manager for Dyneema Purity® at the Biomedical Materials Division of DSM Biomedical, where he created and managed multi-disciplinary business development programs for reaching medical device decision-makers involved in biomaterial selection to drive sales growth. Previously, he was a clinical sales representative for Ethicon Products, Inc., a leading provider of medical devices for the cardiovascular, orthopedic, neurovascular and general surgery markets. In his role at Secant Medical, McGinnis will handle expanding sales in the cardiovascular market segment.
According to Karen West, general manager of Secant Medical, the expansion of the company's business development team was carefully timed. "Secant Medical has taken aggressive steps to solidify our position as the leading provider and innovator in biomedical textile structures for the medical device industry. Last year, our company was acquired by Fenner PLC, a large, international company with expertise in a wide variety of industries. Their support helps ensure Secant Medical is able to capitalize on its capabilities in engineering, operations, and other key areas to continue providing the most innovative textile-based solutions for use in the device industry's latest innovations."
Biomedical textiles from Secant Medical are used in devices in cardiovascular, orthopedics, tissue engineering, general surgery and neurology. The company counts many of the world's leading medical device companies among its customer base.
About Secant Medical: Secant Medical™, LLC is the leader in custom-developed biomedical textile structures for medical devices, helping customers meet challenges to bring device solutions to market quickly and effectively. Using constantly evolving high-performance metallic and polymeric biomaterials, the company designs the textile structures that client innovations require in developing the next generation orthopedic, cardiovascular, tissue-engineered and neurological devices, and new general surgery resources. Secant Medical is a business unit of Prodesco, Inc., the leader in the design, development and manufacture of engineered fabric structures for the medical, industrial and aerospace industries since 1943. In 2008, Prodesco became part of Fenner PLC, a worldwide leader in reinforced polymer engineering headquartered in Yorkshire, England. For more information, contact Jeff Koslosky, at 215-257-8680, extension 159; email jeff.koslosky@secantmedical.com; or visit www.secantmedical.com.